glp-1 medications market comparison Receptor Agonists Obesity Drugs Size, Trends, Growth Report 2032 GLP-1 Weight Loss Drug Market

Cell Host Microbe 23 , 691692 (2018)

For now, there is no FDA approval for the use of GLP-1/GIP medications for T1D

This is in comparison to synthetic sources such as Hydroquinone, which is said to be unsafe and leads to liver damage If we explore this a bit further however, we are aware that under certain alkaline conditions, natural arbutin can still convert into Hydroquinone, which means that it becomes unsafe in some circumstances

Assembly of plasmonic and magnetic nanoparticles with fluorescent silica shell layer for tri-functional SERS-magnetic-fluorescence probes and its bioapplications

This is similar to how a car engine produces exhaust while burning fuel